Advertisement

Topics

PBOA Praises Enactment of FDARA

08:25 EDT 23 Aug 2017 | PharmPro

The Pharma & Biopharma Outsourcing Association is pleased that H.R. 2430, the FDA Reauthorization Act (FDARA), has been signed into law, renewing four major user fee agreements between industry and FDA for FY2018 to FY2022.
Contributed Author: 
 Pharma & Biopharma Outsourcing Association (PBOA)
Topics: 

Original Article: PBOA Praises Enactment of FDARA

NEXT ARTICLE

More From BioPortfolio on "PBOA Praises Enactment of FDARA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...